A Case of Heterozygous INS Gene Missense Variant in Neonatal Diabetes with Beta-Cell Autoantibodies: Experience in Limited Resources Setting
In settings where genetic testing is limited, cautious sulfonylurea use based on clinical algorithms is recommended. Regular monitoring of sulfonylurea response, pancreatic autoantibodies, and β-cell function is essential to guide therapy adjustments.
Authors
- Nur Rochmah (ORCID: https://orcid.org/0000-0002-9626-9615)
- Rayi Kurnia Perwitasari (ORCID: https://orcid.org/0000-0002-8699-4063)
- Aman B Pulungan (ORCID: https://orcid.org/0000-0003-4895-4105)
- Yuni Hisbiyah (ORCID: https://orcid.org/0000-0002-1362-108X)
- Abdulsalam Abu‐Libdeh (ORCID: https://orcid.org/0000-0003-1160-3547)
- Calcarina Nira Pramesthi
- Muhammad Faizi (ORCID: https://orcid.org/0000-0002-1208-0744)
- Aditya Primadana
- Evhy Apryani
Institutions
- Universitas Airlangga (ID)
- University of Indonesia (ID)
- Indonesian Pediatric Society (ID)
- Al-Makassed Islamic Charitable Society Hospital (IL)
- Universitas Dr. Soetomo (ID)
Publication Details
- Journal
- Hormone Research in Paediatrics
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1159/000548319
- Primary Topic
- Pancreatic function and diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00